Thursday, June 11, 2020 (HealthDay News)-Study to evaluate some Drug Currently used for treatment COVID-19 (New Coronavirus Infection) Infants, children, teens Announced by the U.S. National Laboratory Child health And human development (NICHD).
The· DrugOff-label prescriptions are given to children, including antiviral and anti-inflammatory drugs. That is, it has not been specifically tested or approved for use in children.
Drugs are added or removed from the list of drugs given to patients under the age of 21 COVID-19 (New Coronavirus Infection) As researchers learn more about treating these patients, according to NICHD, which is funding the study.
This study, which is conducted at 40 locations nationwide, is not a clinical trial using a control group. Instead, a healthcare provider who is already treating a young patient with a drug on the list will enroll the patient with the consent of their parents or guardians.
In addition to analyzing blood samples to determine how the drug moves through the body of young patients, researchers collect information about potential side effects and patient outcomes.
Research results are used to improve drug administration and improve the safety of young patients COVID-19 (New Coronavirus Infection)However, it is not designed to determine which drug is the best treatment for these patients.
“When we are looking for a safe and effective treatment COVID-19 (New Coronavirus Infection)Dr. Diana Bianchi, director of NICHD, said in a news release at the institute.
Copyright © 2019 Health Day. all rights reserved.
The study evaluates drugs used to treat young COVID-19 patients
Source link The study evaluates drugs used to treat young COVID-19 patients